2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow alicapistat: new trials by email Literature Review of alicapistat trials Research Report on alicapistat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment ABT-957, Placebo - Alzheimer's Disease, Mild Cognitive Impairment | Phase 1 | Terminated | AbbVie | 8 | 2015-12-01 | 2021-07-06 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors ABT-957, Placebo for ABT-957 - Alzheimer's Disease | Phase 1 | Terminated | AbbVie | 19 | 2014-09-01 | 2021-07-06 |
Alzheimer Disease (2) · Cognitive Dysfunction (1)
AbbVie (2)
United States (2)